检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:郝悦 吕新亮 HAO Yue;LV Xin-liang(Inner Mongolia Medical University,Hohhot 010110,Inner Mongolia;Inner Mongolia traditional Chinese medicine hospital,Hohhot 010000,Inner Mongolia)
机构地区:[1]内蒙古医科大学,内蒙古呼和浩特010110 [2]内蒙古自治区中医医院风湿免疫科,内蒙古呼和浩特010000
出 处:《内蒙古中医药》2021年第2期138-140,共3页Inner Mongolia Journal of Traditional Chinese Medicine
基 金:内蒙古自治区科技计划项目(46002827-4)。
摘 要:类风湿关节炎(RA)是一种病因未明的自身免疫反应导致的慢性全身性炎症性疾病,属于中医学“痹病”范畴,目前尚未找到根治的办法。中成药治疗RA已有悠久的历史,其疗效及安全性已获得广泛认可。本文回顾近几年文献,就丸剂、颗粒剂、片剂、胶囊剂等制剂形态的中成药治疗RA的研究进展进行综述。Rheumatoid arthritis(RA)is a chronic systemic inflammatory disease caused by autoimmune reaction with unknown etiology.It belongs to the category of"Bi disease"in traditional Chinese medicine,and no radical method has been found.Chinese patent medicine has a long history in the treatment of RA,and its efficacy and safety have been widely recognized.This article reviews the literature in recent years,and reviews the research progress of Chinese patent medicine in the form of pills,granules,tablets,capsules and other preparations in the treatment of RA.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222